{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:48:32Z","timestamp":1779331712406,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017037","name":"Cepheid.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017037","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jgar.2020.08.011","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T23:48:08Z","timestamp":1599004088000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Does the presence of multiple \u03b2-lactamases in Gram-negative bacilli impact the results of antimicrobial susceptibility tests and extended-spectrum \u03b2-lactamase and carbapenemase confirmation methods?"],"prefix":"10.1016","volume":"23","author":[{"given":"Fred C.","family":"Tenover","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin M.","family":"dela Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Dewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria M.","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1379-583X","authenticated-orcid":false,"given":"Isabella A.","family":"Tickler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2020.08.011_bib0005","unstructured":"World Health Organization (WHO). Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities n.d. https:\/\/www.who.int\/infection-prevention\/publications\/guidelines-cre\/en\/."},{"issue":"Suppl 1","key":"10.1016\/j.jgar.2020.08.011_bib0010","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace","volume":"215","author":"Logan","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2020.08.011_bib0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/JCM.02771-15","article-title":"The problem of carbapenemase-producing-carbapenem-resistant-Enterobacteriaceae detection","volume":"54","author":"Lutgring","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2020.08.011_bib0020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.diagmicrobio.2018.10.004","article-title":"Diversity of resistance mechanisms in carbapenem-resistant Enterobacteriaceae at a health care system in Northern California, from 2013 to 2016","volume":"93","author":"Senchyna","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2020.08.011_bib0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/jac\/dkw398","volume":"72","author":"Jean","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.08.011_bib0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/cid\/cis942","article-title":"Community-associated extended-spectrum \u03b2-lactamase-producing Escherichia coli infection in the United States","volume":"56","author":"Doi","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2020.08.011_bib0035","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011\u20132014","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2020.08.011_bib0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/IDR.S233808","article-title":"Molecular epidemiology and mechanisms of high-level resistance to meropenem and imipenem in Pseudomonas aeruginosa","volume":"13","author":"Hassuna","year":"2020","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2020.08.011_bib0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2147\/IDR.S228089","article-title":"Acinetobacter baumannii efflux pumps and antibiotic resistance","volume":"13","author":"Abdi","year":"2020","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2020.08.011_bib0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/cid\/ciw741","article-title":"Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia","volume":"64","author":"Tamma","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2020.08.011_bib0055","series-title":"Facility Guidance for Control of Carbapenem-Resistant Enterobacteriaceae (CRE). November 2015 update 2015","author":"US Centers for Disease Control and Prevention (CDC)","year":"2015"},{"key":"10.1016\/j.jgar.2020.08.011_bib0060","doi-asserted-by":"crossref","first-page":"e01757","DOI":"10.1128\/JCM.01757-18","article-title":"EDTA-modified carbapenem inactivation method: a phenotypic method for detecting metallo-\u03b2-lactamase-producing Enterobacteriaceae","volume":"57","author":"Sfeir","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2020.08.011_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2019.03.003","article-title":"Comparison of five methods for detection of carbapenemases in Enterobacterales with proposal of a new algorithm","volume":"25","author":"Baeza","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2020.08.011_bib0070","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1128\/JCM.00818-07","article-title":"Metallo-\u03b2-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates","volume":"46","author":"Pic\u00e3o","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2020.08.011_bib0075","doi-asserted-by":"crossref","first-page":"e00272","DOI":"10.1128\/JCM.00272-18","article-title":"Multicenter evaluation of the Xpert Carba-R assay for detection of carbapenemase genes in Gram-negative isolates","volume":"56","author":"Traczewski","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2020.08.011_bib0080","doi-asserted-by":"crossref","first-page":"e01800","DOI":"10.1128\/JCM.01800-18","article-title":"Evaluation of the Amplidiag CarbaR+MCR Kit for accurate detection of carbapenemase-producing and colistin-resistant bacteria","volume":"57","author":"Girlich","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2020.08.011_bib0085","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.diagmicrobio.2017.04.011","article-title":"Performance of the check-points Check-MDR CT103XL assay utilizing the CDC\/FDA antimicrobial resistance isolate bank","volume":"88","author":"Powell","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2020.08.011_bib0090","series-title":"Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. CLSI Supplement M100","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2020"},{"key":"10.1016\/j.jgar.2020.08.011_bib0095","unstructured":"EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and\/or epidemiological importance (2017). https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Resistance_mechanisms\/EUCAST_detection_of_resistance_mechanisms_170711.pdf (accessed July 29, 2020)."},{"issue":"Suppl 1","key":"10.1016\/j.jgar.2020.08.011_bib0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1469-0691.2007.01846.x","article-title":"Phenotypic detection of extended-spectrum \u03b2-lactamase production in Enterobacteriaceae: review and bench guide","volume":"14","author":"Drieux","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"10.1016\/j.jgar.2020.08.011_bib0105","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1093\/cid\/ciy660","article-title":"Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012\u20132016)","volume":"67","author":"Wang","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2020.08.011_bib0110","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/AAC.01896-13","article-title":"Contemporary diversity of \u03b2-lactamases among Enterobacteriaceae in the nine U.S. Census regions and ceftazidime\u2013avibactam activity tested against isolates producing the most prevalent \u03b2-lactamase groups","volume":"58","author":"Castanheira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.08.011_bib0115","doi-asserted-by":"crossref","first-page":"e00709","DOI":"10.1128\/JCM.00709-19","article-title":"Systematic comparison of four methods for detection of carbapenemase-producing Enterobacterales directly from blood cultures","volume":"57","author":"Meier","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2020.08.011_bib0120","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/JCM.00193-17","article-title":"Modified carbapenem inactivation method for phenotypic detection of carbapenemase production among Enterobacteriaceae","volume":"55","author":"Pierce","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2020.08.011_bib0125","unstructured":"CDC & FDA Antibiotic Resistance Isolate Bank. http:\/\/cdc.gov\/drugresistance\/resistance-bank [Accessed 4 August 2020]."},{"key":"10.1016\/j.jgar.2020.08.011_bib0130","series-title":"Performance Standards for Antimicrobial Susceptibility Tests; Approved Standard\u2014Twelfth edition. CLSI Document M02-A12","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2015"},{"key":"10.1016\/j.jgar.2020.08.011_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157718","article-title":"A bacterial analysis platform: an integrated system for analysing bacterial whole genome sequencing data for clinical diagnostics and surveillance","volume":"11","author":"Thomsen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2020.08.011_bib0140","series-title":"Common Statistical Methods for Clinical Research with SAS Examples","author":"Walker","year":"2010"},{"key":"10.1016\/j.jgar.2020.08.011_bib0145","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1128\/AAC.48.6.2043-2048.2004","article-title":"Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa","volume":"48","author":"Girlich","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.08.011_bib0150","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijantimicag.2006.10.008","article-title":"Metallo-\u03b2-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues","volume":"29","author":"Cornaglia","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2020.08.011_bib0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.12688\/wellcomeopenres.12527.1","article-title":"AMR surveillance in low and middle-income settings\u2014a roadmap for participation in the Global Antimicrobial Surveillance System (GLASS) [version 1; peer review: 3 approved]","volume":"2","author":"Seale","year":"2017","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.jgar.2020.08.011_bib0160","unstructured":"EUCAST Expert Rules v 3.2 on Enterobacterales (2019). https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Expert_Rules\/2020\/ExpertRules_V3.2_20190515_Enterobacterales.pdf (accessed August 3, 2020)."},{"key":"10.1016\/j.jgar.2020.08.011_bib0165","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/JCM.39.6.2206-2212.2001","article-title":"Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum \u03b2-lactamases: implications for the clinical microbiology laboratory","volume":"39","author":"Paterson","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2020.08.011_bib0170","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1017\/ice.2020.46","article-title":"Impact of removing ESBL designation from culture reports on the selection of antibiotics for the treatment of infections associated with ESBL-producing organisms","volume":"41","author":"Lesher","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2020.08.011_bib0175","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/jac\/dks088","article-title":"Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?","volume":"67","author":"Livermore","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.08.011_bib0180","doi-asserted-by":"crossref","first-page":"e02015","DOI":"10.1128\/JCM.02015-19","article-title":"Evaluation of the EDTA-modified carbapenem inactivation method (eCIM) for detecting metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa","volume":"58","author":"Gill","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2020.08.011_bib0185","doi-asserted-by":"crossref","first-page":"e01405","DOI":"10.1128\/JCM.01405-18","article-title":"Genome-based prediction of bacterial antibiotic resistance","volume":"57","author":"Su","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2020.08.011_bib0190","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02026-19","article-title":"Reconciling the potentially irreconcilable? Genotypic and phenotypic amoxicillin\u2013clavulanate resistance in Escherichia coli","volume":"64","author":"Davies","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.08.011_bib0195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cmi.2016.11.012","article-title":"The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee","volume":"23","author":"Ellington","year":"2017","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520302174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520302174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:55:41Z","timestamp":1761990941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716520302174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":39,"alternative-id":["S2213716520302174"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2020.08.011","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does the presence of multiple \u03b2-lactamases in Gram-negative bacilli impact the results of antimicrobial susceptibility tests and extended-spectrum \u03b2-lactamase and carbapenemase confirmation methods?","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2020.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}